Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years ADT-Results of the randomized EORTC Phase III trial 22961

被引：0
|
作者：
Bolla, M.
van Tienhoven, G.
de Reijke, T. M.
van den Bergh, A. C.
van der Meijden, A. P.
Poortmans, P. M.
Gez, E.
Kil, P.
Pierart, M.
Collette, L.
机构：
[1] Ctr Hosp Reg Grenoble, Grenoble, France
[2] Acad Med Ctr, Amsterdam, Netherlands
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] Jeroen Bosch Ziekenhuis, Shertogenbosch, Netherlands
[5] Doctor Bernard Verbeeten Inst, Tilburg, Netherlands
[6] Rambam Med Ctr, Haifa, Israel
[7] Sint Elisabethziekenhuis, Tilburg, Netherlands
[8] EORTC Data Ctr, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5014
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run
    Kouloulias, VE
    Giraud, JY
    Davis, BJ
    Dusserre, A
    Zurlo, A
    Bolla, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 (01) : 11 - 20
  • [32] Final Analysis of Intergroup Randomized Phase III Study of Androgen Deprivation Therapy (ADT) ± Radiation Therapy (RT) in Locally Advanced Prostate Cancer (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)
    Gospodarowicz, M. K.
    Mason, M.
    Parulekar, W.
    Swanson, G.
    Kirkbride, P.
    Brundage, M.
    Sydes, M.
    Hetherington, J.
    Chen, B.
    Warde, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S4 - S4
  • [33] Bone metabolism biomarkers (BMB) in hormone sensitive prostate cancer (HSPC): Results from SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) plus /- orteronel
    Lara, P. N.
    Mayerson, E.
    Gertz, E.
    Tangen, C.
    Goldkorn, A.
    van Loan, M.
    Hussain, M.
    Gupta, S.
    Zhang, J.
    Twardowski, P.
    Quinn, D. I.
    Vogelzang, N. J.
    Thompson, I.
    Agarwal, N.
    ANNALS OF ONCOLOGY, 2018, 29 : 275 - U475
  • [34] Intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)
    Warde, P. R.
    Mason, M. D.
    Sydes, M. R.
    Gospodarowicz, M. K.
    Swanson, G. P.
    Kirkbride, P.
    Kostashuk, E.
    Hetherington, J.
    Ding, K.
    Parulekar, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [35] INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION IN PATIENTS WITH RELAPSING OR LOCALLY ADVANCED PROSTATE CANCER: A PHASE 3B RANDOMIZED STUDY (ICELAND)
    Schulman, Claude
    Cornel, Erik
    Matveev, Vsevolod
    Schraml, Jan
    Bensadoun, Henri
    Warnack, Wolfgang
    Persad, Raj
    Salagierski, Marek
    Gomez Viega, Francisco
    Baskin-Bey, Edwina
    Lopez, Beatriz
    Tombal, Bertrand
    JOURNAL OF UROLOGY, 2015, 193 (04): : E938 - E938
  • [36] Final report of a Canadian phase III trial of 3 vs 8 months Neoadjuvant androgen deprivation prior to 66 gray external beam radiotherapy for clinically localized prostate cancer
    Crook, J. M.
    Ludgate, C.
    Malone, S.
    Eapen, L.
    Perry, G.
    Bowen, J.
    Robertson, S.
    Lockwood, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S75 - S75
  • [37] Intergroup Randomized Phase 3 Study of Androgen Deprivation Therapy (ADT) plus Radiation Therapy (RT) in Locally Advanced Prostate Cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, and INT: T94-0110; NCT00002633)
    Mason, M. D.
    Warde, P. R.
    Sydes, M. R.
    Gospodarowicz, M. K.
    Swanson, G. P.
    Kirkbrides, P.
    Kostashuk, E.
    Hetherington, J.
    Ding, K.
    Parulekar, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S2 - S2
  • [38] A phase 3 trial of SHR3680 versus bicalutamide in combination with androgen deprivation therapy (ADT) in patients with high-volume metastatic hormone-sensitive prostate cancer (mHSPC).
    Ye, Ding-Wei
    Gu, Weijie
    Han, Weiqing
    Luo, Hong
    Zhou, Fangjian
    He, Dalin
    Ma, Lulin
    Guo, Hongqian
    Liang, Chaozhao
    Chong, Tie
    Jiang, Jun
    Chen, Zhiwen
    Wang, Yong
    Zou, Qing
    Tian, Ye
    Xiao, Jun
    Huang, Jian
    Yang, Xinfeng
    Li, Junliang
    Jin, Chunlei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] COMPARISON OF QUALITY OF LIFE IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER TREATED WITH NEOADJUVANT ENDOCRINE, EXTERNAL BEAM RADIATION AND ADJUVANT CONTINUOUS/INTERMITTENT ENDOCRINE THERAPY IN RANDOMIZED PHASE III TRIAL
    Yokomizo, Akira
    Koga, Hirofumi
    Ito, Kazuto
    Suzuki, Kazuhiro
    Yamanaka, Hidetoshi
    Naito, Seiji
    JOURNAL OF UROLOGY, 2016, 195 (04): : E320 - E320
  • [40] Randomized phase II-III trial of concomitant CT/RT versus TPF followed by concomitant CT/RT in locally advanced squamous cell carcinoma of the head and neck (LASCCHN). Results of the phase II part of the study
    Ghi, Maria Grazia
    Paccagnella, Adriano
    Koussis, Haralabos
    Mastromauro, Cataldo
    Morandini, Giorgio
    Bonetti, Andrea
    Galligioni, Enzo
    Gardani, Gianstefano
    Orlando, Antonio
    Ferrara, Stefano
    ANNALS OF ONCOLOGY, 2006, 17 : 179 - 179
12345